Kronos Bio has given up on its only drug in clinical trials after some patients suffered neurological problems like ...
Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - BOSTON and ...
Former college swimmer Riley Gaines repeatedly mocked Rep. Alexandria Ocasio-Cortez, D-N.Y., on social media on Thursday ...
Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...
MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...
The final battle was waged last week when President-elect Donald Trump won victory. As some conservatives explain it, the ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...
The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...
Bio-based materials may pose a greater health risk to some of the planet's most important species than the conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback